Brexucabtagene Autoleucel
Severe
Database
Clinical effect not specified
Source: DDInter
Drug reference
flunisolide
Topical corticosteroid · Anti-inflammatory, Anti-allergic
Topical corticosteroidAnti-inflammatory, Anti-allergic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
5 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 5 →
- Brexucabtagene AutoleucelSevereDatabaseDDInter
- CladribineSevereDatabaseDDInter
- DesmopressinSevereDatabaseDDInter
- DinutuximabSevereDatabaseDDInter
Mechanism
Not yet extracted
Indications
Prophylaxis and treatment of seasonal and perennial rhinitis
Dosing
- Adult
- 25 µg per actuation nasal spray; one spray in each nostril 2–3 times daily
Drug interactions
Cladribine
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Desmopressin
Severe
Database
Clinical effect not specified
Source: DDInter
Dinutuximab
Severe
Database
Clinical effect not specified
Source: DDInter
Mifepristone
Severe
Database
Drug interaction classified as: antagonism, metabolism
Source: DDInter
7 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Related guidelines
Inflammatory bowel disease
OTHER · Gastroenterology · 2015
Venous thromboembolism prophylaxis
ASH · Haematology · 2018
Preventive care in inflammatory bowel disease
ACG · Gastroenterology · 2025
Plaque psoriasis
IADVL · Dermatology · 2022
Infective endocarditis prevention
NICE · Cardiology / Dentistry · 2008
Ask House about flunisolide
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team